EN DE
STOCK COMPARISON

Danaher vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how Danaher (DHR) and Thermo Fisher Scientific (TMO) compare, as of Aug 8, 2026.

As of Aug 8, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Danaher trades at $200 versus a fair value of $104 (-48%), while Thermo Fisher Scientific trades at $580 versus $308 (-47%).
Danaher
DHR · USD · Health Care
-48%
upside to fair value
overvalued
Price$200
Fair Value$104
Quality67/100
Thermo Fisher Scientific
TMO · USD · Health Care
-47%
upside to fair value
overvalued
Price$580
Fair Value$308
Quality64/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

DanaherThermo Fisher Scientific
Valuation
38.6×P/E (TTM)29.5×
5.69×P/S (TTM)4.41×
2.68×P/B3.74×
19.5×EV/EBITDA20.0×
1.27×PEG1.74×
0.7%Dividend yield0.3%
$1.36Dividend per share$1.76
Profitability
15%Net margin15%
23%Operating margin18%
7%Return on equity14%
4%Return on assets5%
Growth
4%Revenue growth (YoY)6%
-2.7%Avg. growth/yr (3Y)-0.3%
2.0%Avg. growth/yr (5Y)6.7%
Balance & size
0.35×Debt / equity0.67×
$141BMarket cap$199B
healthyGrowth qualityhealthy

Thermo Fisher Scientific leads: 6 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Danaherof which business quality 70 · market factors 50 Thermo Fisher Scientificof which business quality 60 · market factors 63
ProfitabilityMargins and returns on capital today
37
43
Quality GrowthAre margins and returns improving?
41
31
CashflowEarnings quality: real cash, not paper profit
85
62
Fin. StrengthBalance sheet, leverage, solvency risk
79
60
InvestmentDisciplined investing over empire-building
92
79
Low VolatilityCalm price path (market factor)
70
68
MomentumPrice trend over the last 3–12 months (market factor)
42
56
52W MomentumDistance to the 52-week high (market factor)
42
68
Net IssuanceBuybacks instead of dilution
98
97

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Danaher

DCF Models$117
Earnings-Based$50.84
Dividend Discount$21.83
Multiples$94.46
Asset-Based$49.73
Growth DCF$114
Economic Profit$57.11
Growth Earnings$85.06

26 of 26 models see the stock below the current price.

Thermo Fisher Scientific

DCF Models$331
Earnings-Based$203
Multiples$310
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$324

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Danaher
Bear $65.48Fair Value $104Bull $135
$200 = current price (white tick)
Thermo Fisher Scientific
Bear $175Fair Value $308Bull $385
$580 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Danaher · Health Care

Quality score67 · Top 25%
Fair value upside-48% · below median

Thermo Fisher Scientific · Health Care

Quality score64 · Top 25%
Fair value upside-47% · below median

Bottom line

As of Aug 8, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Danaher trades at $200 versus a fair value of $104 (-48%), while Thermo Fisher Scientific trades at $580 versus $308 (-47%).

Danaher has the higher quality score (67/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.